1287403004: Filgotinib maleate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Janus kinase inhibitor\Filgotinib maleate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Filgotinib maleate (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Pyridine\Filgotinib maleate (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Filgotinib maleate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5258024011 Filgotinib maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5258025012 Filgotinib maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Filgotinib maleate (substance)	Is a	Pyridine	true	Inferred relationship	Some
Filgotinib maleate (substance)	Is a	Janus kinase inhibitor	true	Inferred relationship	Some
Filgotinib maleate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Janus kinase inhibitor (disposition)	true	Inferred relationship	Some
Filgotinib maleate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Filgotinib	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely filgotinib (as filgotinib maleate) 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Filgotinib maleate (substance)	Inferred relationship	Some	1
Filgotinib (as filgotinib maleate) 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Filgotinib maleate (substance)	Inferred relationship	Some	1

This concept is not in any reference sets